Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Cheng, Ph.D.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Cheng D, Fung V, Shah R, Goldberg S, Lee B, Song G, Doane J, Kingsley M, Henley P, Banthin C, Winickoff JP, Rigotti NA, Levy DE. Smoke-Free Policies and Resident Turnover: An Evaluation in Massachusetts Public Housing From 2009?2018. Am J Prev Med. 2023 Jan 10. PMID: 36635198.
    Citations:    Fields:    
  2. Lee B, Fung V, Cheng D, Winickoff JP, Rigotti NA, Shah R, McGlave C, Goldberg S, Song G, Doane J, Kingsley M, Henley P, Ursprung S, Banthin C, Levy DE. Implementation Activities in Smoke-Free Public Housing: The Massachusetts Experience. Int J Environ Res Public Health. 2022 Dec 21; 20(1). PMID: 36612394; PMCID: PMC9819479.
    Citations:    Fields:    Translation:HumansPHPublic Health
  3. Cheng D, Tchetgen ET, Signorovitch J. On the double-robustness and semiparametric efficiency of matching-adjusted indirect comparisons. Res Synth Methods. 2022 Dec 20. PMID: 36537355.
    Citations:    Fields:    
  4. Hull LE, Cheng D, Hallman MH, Rieu-Werden ML, Haas JS. Association of Patient and Site-of-Care Characteristics With Reproductive Carrier Screening Timing in a Large Integrated Health System. JAMA Netw Open. 2022 11 01; 5(11):e2240829. PMID: 36346628; PMCID: PMC9644263.
    Citations:    Fields:    Translation:Humans
  5. Lang R, Humes E, Hogan B, Lee J, D'Agostino R, Massaro J, Kim A, Meigs JB, Borowsky L, He W, Lyass A, Cheng D, Kim HN, Klein MB, Cachay ER, Bosch RJ, Gill MJ, Silverberg MJ, Thorne JE, McGinnis K, Horberg MA, Sterling TR, Triant VA, Althoff KN. Evaluating the Cardiovascular Risk in an Aging Population of People With HIV: The Impact of Hepatitis C Virus Coinfection. J Am Heart Assoc. 2022 10 04; 11(19):e026473. PMID: 36129038; PMCID: PMC9673707.
    Citations:    Fields:    Translation:HumansCells
  6. Cheng D, Kochar B, Cai T, Ritchie CS, Ananthakrishnan AN. Comorbidity Influences the Comparative Safety of Biologic Therapy in Older Adults With Inflammatory Bowel Diseases. Am J Gastroenterol. 2022 11 01; 117(11):1845-1850. PMID: 35854436; PMCID: PMC9633357.
    Citations:    Fields:    
  7. Chang MS, La J, Trepanowski N, Cheng D, Bihn JR, Do N, Brophy M, Fillmore NR, Hartman RI. Increased relative proportions of advanced melanoma among veterans: A comparative analysis with the Surveillance, Epidemiology, and End Results registry. J Am Acad Dermatol. 2022 07; 87(1):72-79. PMID: 35595121.
    Citations:    Fields:    Translation:Humans
  8. Cheng D, Dumontier C, Sheikh AR, La J, Brophy MT, Do NV, Driver JA, Tuck DP, Fillmore NR. Prognostic value of the veterans affairs frailty index in older patients with non-small cell lung cancer. Cancer Med. 2022 08; 11(15):3009-3022. PMID: 35338613; PMCID: PMC9359868.
    Citations:    Fields:    
  9. Shahian DM, McCloskey D, Liu X, Schneider E, Cheng D, Mort EA. The association of hospital research publications and clinical quality. Health Serv Res. 2022 06; 57(3):587-597. PMID: 35124806; PMCID: PMC9108066.
    Citations: 1     Fields:    Translation:Humans
  10. Kochar BD, Cheng D, Cai T, Ananthakrishnan AN. Comparative Risk of Thrombotic and Cardiovascular Events with Tofacitinib and Anti-TNF Agents in Patients with Inflammatory Bowel Diseases. Dig Dis Sci. 2022 11; 67(11):5206-5212. PMID: 35113275.
    Citations:    Fields:    
  11. Cheng D, Kochar BD, Cai T, Ananthakrishnan AN. Risk of Infections With Ustekinumab and Tofacitinib Compared to Tumor Necrosis Factor a Antagonists in Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2022 10; 20(10):2366-2372.e6. PMID: 35066137; PMCID: PMC9296690.
    Citations: 1     Fields:    
  12. Foulkes AS, Selvaggi C, Shinnick D, Lumish H, Kim E, Cao T, Thaweethai T, Qian J, Lu F, Yan J, Cheng D, He W, Clerkin KJ, Madhavan MV, Meigs JB, Triant VA, Lubitz SA, Gupta A, Bassett IV, Reilly MP. Understanding the Link Between Obesity and Severe COVID-19 Outcomes: Causal Mediation by Systemic Inflammatory Response. J Clin Endocrinol Metab. 2022 01 18; 107(2):e698-e707. PMID: 34473294; PMCID: PMC8499919.
    Citations: 4     Fields:    Translation:Humans
  13. Haas JS, Cheng D, Yu L, Atlas SJ, Clark C, Feldman S, Silver MI, Kamineni A, Chubak J, Pocobelli G, Tiro JA, Kobrin SC. Variation in the receipt of human papilloma virus co-testing for cervical screening: Individual, provider, facility and healthcare system characteristics. Prev Med. 2022 01; 154:106871. PMID: 34762966; PMCID: PMC8724456.
    Citations:    Fields:    Translation:HumansCellsPHPublic Health
  14. Marcondes FO, Cheng D, Alegria M, Haas JS. Are racial/ethnic minorities recently diagnosed with diabetes less likely than white individuals to receive guideline-directed diabetes preventive care? BMC Health Serv Res. 2021 Oct 25; 21(1):1150. PMID: 34689778; PMCID: PMC8543926.
    Citations:    Fields:    Translation:Humans
  15. Fillmore NR, DuMontier C, Yildirim C, La J, Epstein MM, Cheng D, Cirstea D, Yellapragada S, Abel GA, Gaziano JM, Do N, Brophy M, Kim DH, Munshi NC, Driver JA. Defining Multimorbidity and Its Impact in Older United States Veterans Newly Treated for Multiple Myeloma. J Natl Cancer Inst. 2021 08 02; 113(8):1084-1093. PMID: 33523236; PMCID: PMC8328982.
    Citations: 2     Fields:    Translation:Humans
  16. Marcondes FO, Cheng D, Warner ET, Kamran SC, Haas JS. The trajectory of racial/ethnic disparities in the use of cancer screening before and during the COVID-19 pandemic: A large U.S. academic center analysis. Prev Med. 2021 10; 151:106640. PMID: 34217419; PMCID: PMC8262076.
    Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
  17. DuMontier C, Fillmore NR, Yildirim C, Cheng D, La J, Orkaby AR, Charest B, Cirstea D, Yellapragada S, Gaziano JM, Do N, Brophy MT, Kim DH, Munshi NC, Driver JA. Contemporary Analysis of Electronic Frailty Measurement in Older Adults with Multiple Myeloma Treated in the National US Veterans Affairs Healthcare System. Cancers (Basel). 2021 Jun 18; 13(12). PMID: 34207459.
    Citations: 2     
  18. Cheng D, DuMontier C, Yildirim C, Charest B, Hawley CE, Zhuo M, Paik JM, Yaksic E, Gaziano JM, Do N, Brophy M, Cho K, Kim DH, Driver JA, Fillmore NR, Orkaby AR. Updating and Validating the U.S. Veterans Affairs Frailty Index: Transitioning From ICD-9 to ICD-10. J Gerontol A Biol Sci Med Sci. 2021 06 14; 76(7):1318-1325. PMID: 33693638; PMCID: PMC8202143.
    Citations: 5     Fields:    Translation:Humans
  19. Hartman RI, La J, Chang MS, Cheng D, Do N, Brophy M, Fillmore NR. Risk factors for thick melanoma among veterans: A cross-sectional study. J Am Acad Dermatol. 2021 Jun; 84(6):1766-1769. PMID: 33422630.
    Citations:    Fields:    Translation:Humans
  20. David Cheng, Rajeev Ayyagari, James Signorovitch. The Statistical Performance of Matching-Adjusted Indirect Comparisons: Estimating Treatment Effects with Aggregate External Control Data. Annals of Applied Statistics. 2020; 4(14):1806-1833.
  21. La J, Cheng D, Brophy MT, Do NV, Lee JSH, Tuck D, Fillmore NR. Real-World Outcomes for Patients Treated With Immune Checkpoint Inhibitors in the Veterans Affairs System. JCO Clin Cancer Inform. 2020 10; 4:918-928. PMID: 33074743.
    Citations: 8     Fields:    Translation:Humans
  22. Cheng D, Ananthakrishnan AN, Cai T. Robust and efficient semi-supervised estimation of average treatment effects with application to electronic health records data. Biometrics. 2021 06; 77(2):413-423. PMID: 32413171; PMCID: PMC7758040.
    Citations:    Fields:    Translation:Humans
  23. Cheng D, Cushing KC, Cai T, Ananthakrishnan AN. Safety and Efficacy of Tumor Necrosis Factor Antagonists in Older Patients With Ulcerative Colitis: Patient-Level Pooled Analysis of Data From Randomized Trials. Clin Gastroenterol Hepatol. 2021 05; 19(5):939-946.e4. PMID: 32371165.
    Citations: 8     Fields:    Translation:Humans
  24. Cheng D, Chakrabortty A, Ananthakrishnan AN, Cai T. Estimating average treatment effects with a double-index propensity score. Biometrics. 2020 09; 76(3):767-777. PMID: 31797368; PMCID: PMC7370895.
    Citations: 3     Fields:    Translation:Humans
  25. Cheng D, Ramos-Cejudo J, Tuck D, Elbers D, Brophy M, Do N, Fillmore N. External validation of a prognostic model for mortality among patients with non-small-cell lung cancer using the Veterans Precision Oncology Data Commons. Semin Oncol. 2019 Aug - Oct; 46(4-5):327-333. PMID: 31708233.
    Citations: 1     Fields:    Translation:Humans
  26. Pellegrini F, Copetti M, Bovis F, Cheng D, Hyde R, de Moor C, Kieseier BC, Sormani MP. A proof-of-concept application of a novel scoring approach for personalized medicine in multiple sclerosis. Mult Scler. 2020 08; 26(9):1064-1073. PMID: 31144577.
    Citations: 5     Fields:    Translation:Humans
  27. Ayyagari R, Xie J, Cheng D, Wu EQ, Huang XY, Chen S. A retrospective study evaluating the tolerability and effectiveness of adjunctive antihypertensive drugs in patients with inadequate response to initial treatment. J Clin Hypertens (Greenwich). 2018 06; 20(6):1058-1066. PMID: 29902367.
    Citations: 1     Fields:    Translation:Humans
  28. Cheng D, Pak K, Wei LJ. Demonstrating Noninferiority of Accelerated Radiotherapy With Panitumumab vs Standard Radiotherapy With Cisplatin in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma. JAMA Oncol. 2017 10 01; 3(10):1430-1431. PMID: 28750125; PMCID: PMC7371341.
    Citations: 3     Fields:    
  29. Setyawan J, Yang H, Cheng D, Cai X, Signorovitch J, Xie J, Erder MH. Developing a Risk Score to Guide Individualized Treatment Selection in Attention Deficit/Hyperactivity Disorder. Value Health. 2015 Sep; 18(6):824-31. PMID: 26409610.
    Citations: 2     Fields:    Translation:Humans
  30. Ayyagari R, Wei W, Cheng D, Pan C, Signorovitch J, Wu EQ. Effect of adherence and insulin delivery system on clinical and economic outcomes among patients with type 2 diabetes initiating insulin treatment. Value Health. 2015 Mar; 18(2):198-205. PMID: 25773555.
    Citations: 18     Fields:    Translation:Humans
  31. Sun SX, Marynchenko M, Banerjee R, Cheng D, Mocarski M, Yin D, Yu AP, Wu EQ. Cost-effectiveness analysis of roflumilast/tiotropium therapy versus tiotropium monotherapy for treating severe-to-very severe COPD. J Med Econ. 2011; 14(6):805-15. PMID: 21992217.
    Citations: 4     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Cheng's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (140)
Explore
_
Co-Authors (44)
Explore
_
Similar People (59)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.